The mechanisms whereby integrins signal to the interior of the cell are essentially unknown. We have found a new and potentially important lead to these signaling mechanisms. We found that the intracellular protein that mediates signalling from the insulin receptor, insulin receptor substrate 1 (IRS-1) becomes associated with alpha/v integrins when cells are stimulated with insulin. This novel connection between growth factor signaling and integrins will be studied in this proposal. The first part of the study will explore the mechanism of the integrin - IRS-1 association to determine whether IRS-1 binds directly to the integrin cytoplasmic domain or whether another protein might mediate the interaction. We will also determine whether other proteins bind to the integrin - IRS-1 complex and determine the identities of such proteins, if found. We have only studied insulin so far; insulin-like growth factor (IGF) and interleukin 4 (IL-4) are also known to signal through IRS-1. We will test the ability of these two cytokines to cause the integrin association of IRS-1. Preliminary results show that the alpha/v/beta/3 integrin and probably also some other alpha/v integrins bind IRS-1, whereas beta/1 integrins have not shown any IRS-1 binding. Antibodies to various integrin subunits will be used to establish the integrin specificity of the IRS-1 association. Next, cDNA transfections, as well as cell growth, adhesion and migration assays will be used to determine how the integrin-IRS-1 association might affect insulin signaling and integrin function. The integrin-IRS-1 association is an exciting new link between integrins and growth factors that may shed light in important biological phenomena such as anchorage dependence of growth.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Pathobiochemistry Study Section (PBC)
Program Officer
Mohla, Suresh
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Sanford-Burnham Medical Research Institute
La Jolla
United States
Zip Code
Itano, Naoki; Okamoto, Shu-ichi; Zhang, Dongxian et al. (2003) Cell spreading controls endoplasmic and nuclear calcium: a physical gene regulation pathway from the cell surface to the nucleus. Proc Natl Acad Sci U S A 100:5181-6
Borges, E; Jan, Y; Ruoslahti, E (2000) Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain. J Biol Chem 275:39867-73
Wang, B; Zou, J X; Ek-Rylander, B et al. (2000) R-Ras contains a proline-rich site that binds to SH3 domains and is required for integrin activation by R-Ras. J Biol Chem 275:5222-7
Ruoslahti, E (1999) Fibronectin and its integrin receptors in cancer. Adv Cancer Res 76:1-20
MacKenna, D A; Dolfi, F; Vuori, K et al. (1998) Extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts. J Clin Invest 101:301-10
Bourdoulous, S; Orend, G; MacKenna, D A et al. (1998) Fibronectin matrix regulates activation of RHO and CDC42 GTPases and cell cycle progression. J Cell Biol 143:267-76
Ruoslahti, E (1997) Integrins as signaling molecules and targets for tumor therapy. Kidney Int 51:1413-7
Schneller, M; Vuori, K; Ruoslahti, E (1997) Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J 16:5600-7
Vuori, K; Hirai, H; Aizawa, S et al. (1996) Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases. Mol Cell Biol 16:2606-13
Zhang, Z; Vuori, K; Wang, H et al. (1996) Integrin activation by R-ras. Cell 85:61-9

Showing the most recent 10 out of 13 publications